Cite Filings / NBIX / 0000834237-20-008722
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

NEUROCRINE BIOSCIENCES INC · Filed 2020-02-10 · Acc 0000834237-20-008722

Documents 1

  • SC 13G/A Amended Statement of Ownership , us64125c1099_020720.txt

Around this filing

  • 2020-02-12 SC 13G/A Amended Statement of Ownership
  • 2020-02-11 4 Chief Medical Officer sold 1,623 shares at $103.31 ($167,675)
  • 2020-02-11 4 Chief Regulatory Officer sold 29,984 shares at an average $104.52 ($3,133,912)
  • 2020-02-11 4 Chief Legal Officer sold 1,522 shares at $103.32 ($157,247)
  • 2020-02-11 4 Chief Commercial Officer sold 2,030 shares at $103.32 ($209,747)
  • 2020-02-10 SC 13G/A Amended Statement of Ownership
  • 2020-02-07 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2003-02-14 SC 13G/A · BB Biotech AG N/A 2.5%
  2. 2001-03-22 SC 13G · BIOTECH TARGET S.A. ------------------------------------------------------- N/A 5.4%
Loading us64125c1099_020720.txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…